Back
WuXi Biologics (Cayman) Quote, Financials, Valuation and Earnings
Sponsored
WXIBF
Sponsored
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
78
WXIBF
WuXi Biologics (Cayman)
Last Price:
2.50
Seasonality Move:
2.73%
7 Day Trial
ALL ACCESS PASS
$
7
The dark truth about AI
Click here to learn more...WuXi Biologics (Cayman) Price Quote
$2.50
WuXi Biologics (Cayman) Key Stats
Buy
78
WuXi Biologics (Cayman) (WXIBF)
is a Buy
Day range:
$2.50 - $2.50
52-week range:
$1.30 - $3.92
Dividend yield:
0%
P/E ratio:
22.97
P/S ratio:
4.52
P/B ratio:
1.84%
Volume:
0
Avg. volume:
402
1-year change:
-28.57%
Market cap:
$10.3B
Revenue:
$2.4B
EPS:
$0.08
How Much Does WuXi Biologics (Cayman) Make?
-
How Much Are WuXi Biologics (Cayman)'s Sales Annually?
WXIBF Revenues are $2.4B -
How Much Profit Does WuXi Biologics (Cayman)'s Make A Year?
WXIBF net income is $480.6M
Is WuXi Biologics (Cayman) Growing As A Company?
Data Unavailable
WuXi Biologics (Cayman) Stock Price Performance
-
Did WuXi Biologics (Cayman) Stock Go Up Last Month?
WuXi Biologics (Cayman) share price went up by 11.11% last month -
Did WXIBF's Share Price Rise Over The Last Year?
WXIBF share price fell by -28.57% over the past 1 year
What Is WuXi Biologics (Cayman) 52-Week High & Low?
-
What Is WuXi Biologics (Cayman)’s 52-Week High Share Price?
WuXi Biologics (Cayman) has traded as high as $3.92 over the past 52 weeks -
What Is WuXi Biologics (Cayman)’s 52-Week Low Share Price?
WuXi Biologics (Cayman) has traded as low as $1.30 over the past 52 weeks
WuXi Biologics (Cayman) Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy WuXi Biologics (Cayman)?
-
How Much Debt Does WuXi Biologics (Cayman) Have?
Total long term debt quarterly is $296.8M -
How Much Cash Does WuXi Biologics (Cayman) Have?
Cash and short term investments quarterly total is $1.3B -
What Is WuXi Biologics (Cayman)’s Book Value Per Share?
Book value per share is 1.35
Is WuXi Biologics (Cayman) Cash Flow Positive?
-
What Is WXIBF Cash Flow From Operations?
Cash flow from operations (TTM) is $447.4M -
What Is WuXi Biologics (Cayman)’s Cash Flow From Financing?
Cash flow from financing (TTM) is $93.4M -
What Is WuXi Biologics (Cayman)’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$280.9M
WuXi Biologics (Cayman) Return On Invested Capital
-
Is Management Doing A Good Job?
WXIBF return on invested capital is 5.86% -
What Is WuXi Biologics (Cayman) Return On Assets?
ROA measures how assets are converting to revenues and is 4.8% -
What Is WXIBF Return On Equity?
ROE is a measure of profitability and is 6.19%
WuXi Biologics (Cayman) Earnings Date & Stock Price
-
What Is WuXi Biologics (Cayman)'s Stock Price Today?
A single share of WXIBF can be purchased today for 2.50 -
What Is WuXi Biologics (Cayman)’s Stock Symbol?
WuXi Biologics (Cayman) trades on the otcm under the ticker symbol: WXIBF -
When Is WuXi Biologics (Cayman)’s Next Earnings Date?
The next quarterly earnings date for WuXi Biologics (Cayman) is scheduled on March 26, 2025 -
When Is WXIBF's next ex-dividend date?
WuXi Biologics (Cayman)'s next ex-dividend date is December 15, 2024 -
How To Buy WuXi Biologics (Cayman) Stock?
You can buy WuXi Biologics (Cayman) shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
WuXi Biologics (Cayman) Competitors
-
Who Are WuXi Biologics (Cayman)'s Competitors?
Below is a list of companies who compete with WuXi Biologics (Cayman) or are related in some way:
WuXi Biologics (Cayman) Dividend Yield
-
What Is WXIBF Dividend Yield?
WuXi Biologics (Cayman)’s dividend yield currently is 0% -
What Is WuXi Biologics (Cayman)’s Payout Ratio?
WuXi Biologics (Cayman)’s payout ratio is 0% -
When Did WuXi Biologics (Cayman) Last Pay A Dividend?
The latest dividend pay date is December 15, 2024 -
What Is WuXi Biologics (Cayman)’s Dividend Per Share?
WuXi Biologics (Cayman) pays a dividend of $0.00 per share
WuXi Biologics (Cayman) Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 0.00 |
Downside from Last Price: | -100% |